Entrada Therapeutics
@entradatx
Followers
242
Following
13
Statuses
301
Innovating to transform the treatment of devastating diseases through intracellular therapeutics. #EntradaHere Community guidelines: https://t.co/OKGDgwRdVK
Boston, MA
Joined June 2021
We're moving to LinkedIn! You can continue to follow our updates and news here: #Biotech #EntradaHere #LinkedIn
0
0
2
We’re excited to welcome Gina Chapman to our Board of Directors! Gina’s expertise and proven track record of advancing therapeutics into the market will be crucial as we continue to progress Entrada’s expanding pipeline of intracellular therapeutics. $TRDA
0
1
0
We announced second quarter 2023 financial results today which highlighted our recent approval to initiate a Phase 1 clinical trial for ENTR-601-44 in the United Kingdom as well as the extension of our cash runway through 2025. #BiotechNews $TRDA
0
0
0
Today marks a significant milestone as we received authorization to initiate a Phase 1 clinical trial of ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy in the United Kingdom. #BiotechNews $TRDA
1
1
4
#ICYMI, Entrada unveiled our new headquarters at the Innovation and Design Building in Boston Seaport! Our state-of-the-art lab and office space foster innovation, collaboration and creativity. Join us: #BiotechNews #EntradaHere
0
0
4
We are delighted to continue the tradition of spotlighting our incredible summer interns. Meet Trude Davis, HR & Patient Advocacy Intern, who is a rising senior at @TempleUniv studying Health Professions. #EntradaHere #TempleMade
0
0
3
We prioritize employee well-being by providing the invaluable benefit of @WeAreWellthy, a comprehensive Caregiver Concierge service. Find peace of mind with financial, medical, legal and social/emotional support: #EntradaHere
0
0
0
We're honored to have @KreherNerissa, Chief Medical Officer, and Regan Sherman, Head of Patient Advocacy, representing Entrada at #CPOSummit. See the full agenda and stay tuned for updates: #patientadvocacy #CPO
0
0
2
Last week, 130+ team members celebrated our progress and team spirit on a memorable company boat trip, connecting outside the lab and enjoying laughter on the Boston Harbor. Join us in making a difference in patients' lives: #Biotech #EntradaHere
1
0
3
Our teammates Ashweta Sahni, PhD, and Matt Streeter, PhD, presented at #APS2023. View a copy of the poster presentation:
0
0
1
We’re proud to be building a company where everyone can belong, contribute and grow. Learn more about the values that bind us together below👇🏿👇🏻👇🏾👇🏽#EntradaHere
0
0
3
Our CMO @KreherNerissa shared our exon-skipping programs for people living with Duchenne who are exon 44 or exon 45 skip amenable @ParentProjectMD's conference. Thank you to all who participated, your insights are invaluable. #PPMDConference #DuchenneResearch #DMD
0
0
0
We're proud to announce the publication of our manuscript titled "Endosomal Escape Vehicle Platform Enhances Oligonucleotide Delivery in Neuromuscular Disorders" in @MolTherapy. Congrats to the Entrada team on this significant achievement! #EntradaHere #Duchenne
0
0
1
Wishing all of our Entrada family and friends a safe, happy and relaxing 4th of July! #IndependenceDay #FourthofJuly #4DayWeekend
0
0
0
We’re committed to supporting our employees on their career journey, and sometimes that means leaving Entrada. We are proud of our newest #Entrada Alumni who are beginning advanced degrees at @OhioState and @Cornell. Congratulations to Sriya Sreekanth and Alec Goffin!
0
0
0
Only 3 days left to apply for the Entrada DREAMS Grant Program! Submit your application by June 30th for a chance at one of three $25,000 grants. Apply now: #EntradaDREAMS #GrantProgram #DiversityMatters
0
0
0
Last Friday, we welcomed @Keygan_Miller (Public Training Manager @TrevorProject) to discuss intersectionality and bias, empathetic listening and actionable allyship. Thank you to all who attended our workshop! #EntradaHere #Pride2023 #Inclusivity 🏳️🌈🏳️⚧️
0
0
1
Entrada team members Phallika Mon and Prashant Singh attended the 17th #WRIB2023 last week, where they joined over 1000 professionals from biotech companies, CROs and regulatory agencies to discuss current topics in bioanalysis.
0
0
0
Entrada Therapeutics is participating in the Philly Cell and Gene Therapy Annual Conference in PA from June 23-24, 2023. Catch a presentation by Leo Qian, Co-Founder & VP, Discovery Research, on June 24: #BiotechNews #EntradaHere
0
0
1
We're looking forward to @ParentProjectMD's Annual Conference in Dallas. This important event is a highlight for our team and we’re proud to be a Platinum sponsor. Join our Chief Medical Officer @KreherNerissa who will present on Friday! #PPMDconference
0
1
3